Gary Hennerberg
Director/Board Member at FINDIT
Net worth: 706 753 $ as of 2024-03-30
Profile
Gary Hennerberg is currently the Chief Marketing Officer & Director at BioRegenx, Inc. since 2016 and the Secretary & Director at Findit, Inc. since 2024.
He completed his undergraduate degree at Fort Hays State University in 1978.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOREGENX INC
5.94% | 2024-03-07 | 16,436,000 ( 5.94% ) | 706 748 $ | 2024-03-30 |
FINDIT INC PFD A
0.00% | 2024-03-07 | 108 ( 0.00% ) | 5 $ | 2024-03-30 |
Gary Hennerberg active positions
| Companies | Position | Start |
|---|---|---|
| FINDIT | Director/Board Member | 2024-03-07 |
Former positions of Gary Hennerberg
| Companies | Position | End |
|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding private company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Director/Board Member | - |
Training of Gary Hennerberg
| Fort Hays State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FINDIT | Technology Services |
| Private companies | 1 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding private company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
- Stock Market
- Insiders
- Gary Hennerberg